GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Biopharmaceuticals Co Ltd (XKRX:326030) » Definitions » Other Current Liabilities

SK Biopharmaceuticals Co (XKRX:326030) Other Current Liabilities : ₩188,433 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is SK Biopharmaceuticals Co Other Current Liabilities?

SK Biopharmaceuticals Co's other current liabilities for the quarter that ended in Mar. 2024 was ₩188,433 Mil.

SK Biopharmaceuticals Co's quarterly other current liabilities declined from Sep. 2023 (₩182,495 Mil) to Dec. 2023 (₩182,123 Mil) but then increased from Dec. 2023 (₩182,123 Mil) to Mar. 2024 (₩188,433 Mil).

SK Biopharmaceuticals Co's annual other current liabilities increased from Dec. 2021 (₩123,895 Mil) to Dec. 2022 (₩134,114 Mil) and increased from Dec. 2022 (₩134,114 Mil) to Dec. 2023 (₩182,123 Mil).


SK Biopharmaceuticals Co Other Current Liabilities Historical Data

The historical data trend for SK Biopharmaceuticals Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Biopharmaceuticals Co Other Current Liabilities Chart

SK Biopharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SK Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SK Biopharmaceuticals Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


SK Biopharmaceuticals Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of SK Biopharmaceuticals Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


SK Biopharmaceuticals Co (XKRX:326030) Business Description

Traded in Other Exchanges
N/A
Address
221, Pangyoyeok-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.

SK Biopharmaceuticals Co (XKRX:326030) Headlines

No Headlines